[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE298764T1 - Sektretierter e1/e2 hepatitis c virus-komplex erhalten aus c-terminal verkürzten polypeptiden e1 und e2 - Google Patents

Sektretierter e1/e2 hepatitis c virus-komplex erhalten aus c-terminal verkürzten polypeptiden e1 und e2

Info

Publication number
ATE298764T1
ATE298764T1 AT95928779T AT95928779T ATE298764T1 AT E298764 T1 ATE298764 T1 AT E298764T1 AT 95928779 T AT95928779 T AT 95928779T AT 95928779 T AT95928779 T AT 95928779T AT E298764 T1 ATE298764 T1 AT E298764T1
Authority
AT
Austria
Prior art keywords
polypeptides
hepatitis
secreted
complex obtained
virus complex
Prior art date
Application number
AT95928779T
Other languages
English (en)
Inventor
Mark Selby
Michael Houghton
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron Corp filed Critical Chiron Corp
Priority claimed from PCT/US1995/010035 external-priority patent/WO1996004301A2/en
Application granted granted Critical
Publication of ATE298764T1 publication Critical patent/ATE298764T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT95928779T 1994-07-29 1995-07-26 Sektretierter e1/e2 hepatitis c virus-komplex erhalten aus c-terminal verkürzten polypeptiden e1 und e2 ATE298764T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28295994A 1994-07-29 1994-07-29
US50660895A 1995-07-25 1995-07-25
PCT/US1995/010035 WO1996004301A2 (en) 1994-07-29 1995-07-26 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same

Publications (1)

Publication Number Publication Date
ATE298764T1 true ATE298764T1 (de) 2005-07-15

Family

ID=26961777

Family Applications (2)

Application Number Title Priority Date Filing Date
AT04077562T ATE417109T1 (de) 1994-07-29 1995-07-26 Hepatitis c e2 verkuerzte polypeptid sowie verfahen zu seiner herstellung
AT95928779T ATE298764T1 (de) 1994-07-29 1995-07-26 Sektretierter e1/e2 hepatitis c virus-komplex erhalten aus c-terminal verkürzten polypeptiden e1 und e2

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT04077562T ATE417109T1 (de) 1994-07-29 1995-07-26 Hepatitis c e2 verkuerzte polypeptid sowie verfahen zu seiner herstellung

Country Status (12)

Country Link
US (1) US6326171B1 (de)
EP (2) EP0773957B1 (de)
JP (4) JP3793571B2 (de)
AT (2) ATE417109T1 (de)
CA (1) CA2195312A1 (de)
DE (2) DE69535899D1 (de)
DK (2) DK0773957T3 (de)
ES (2) ES2244965T3 (de)
IL (3) IL114775A (de)
MX (1) MX9700677A (de)
MY (1) MY121563A (de)
PT (1) PT1510580E (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4458556B2 (ja) * 1997-05-06 2010-04-28 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Ｃ型肝炎のｅ２短縮型ポリペプチドの細胞内生成
WO2001047551A2 (en) * 1999-12-01 2001-07-05 Chiron Corporation Eliciting antibodies specific for hepatitis c virus (hcv)
US7439042B2 (en) * 2002-12-16 2008-10-21 Globeimmune, Inc. Yeast-based therapeutic for chronic hepatitis C infection
CN102614510A (zh) * 2004-10-18 2012-08-01 全球免疫股份有限公司 基于酵母的对慢性丙型肝炎感染的治疗
WO2009131681A2 (en) * 2008-04-22 2009-10-29 Rutgers, The State University Hcv e2 construct compositions and methods
US9758794B2 (en) 2008-04-22 2017-09-12 Rutgers, The State University Of New Jersey HCV E2 construct compositions and methods
WO2010033841A1 (en) 2008-09-19 2010-03-25 Globeimmune, Inc. Immunotherapy for chronic hepatitis c virus infection
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN105621806B (zh) * 2016-01-22 2018-10-30 南京贝克特环保科技有限公司 一种快速处理餐厨垃圾废水的生物聚沉氧化工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1049686C (zh) 1987-11-18 2000-02-23 希龙股份有限公司 非ａ和非ｂ肝炎病毒的诊断及疫苗
UA50829C2 (uk) 1989-03-17 2002-11-15 Чірон Корпорейшн Очищений поліпептид, що містить антиген вірусу гепатиту с, полінуклеотид, вектор, клітини, система експресії, моноклональне антитіло, препарат поліклональних антитіл, нуклеотидна проба, аналітичні набори, спосіб виявлення нуклеїнових кислот, способи імуноаналізу, вакцина, спосіб одержання антитіл
EP0398748B1 (de) 1989-05-18 2002-01-09 Chiron Corporation NANBV-Diagnostika: Polynukleotide, geeignet für Reihenuntersuchungen auf Hepatitis C-Virus
WO1992002628A1 (en) 1990-08-02 1992-02-20 Chiron Corporation Expression of human cmv glycoprotein-h using the baculovirus-insect cell expression system
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
RO115446B1 (ro) 1990-11-08 2000-02-28 Chiron Corp Procedeu de obtinere a asialoglicoproteinelor purificate provenind de la virusul hepatitei c
DK0721505T4 (da) 1994-07-29 2006-08-14 Innogenetics Nv Rensede hepatitis C-virus-kappeproteiner til diagnostisk og terapeutisk anvendelse

Also Published As

Publication number Publication date
EP1510580B1 (de) 2008-12-10
JP3793571B2 (ja) 2006-07-05
DK0773957T3 (da) 2005-10-24
DE69535899D1 (de) 2009-01-22
US6326171B1 (en) 2001-12-04
EP0773957A2 (de) 1997-05-21
ES2244965T3 (es) 2005-12-16
MX9700677A (es) 1997-04-30
JP2007006901A (ja) 2007-01-18
ES2316920T3 (es) 2009-04-16
JP2007291126A (ja) 2007-11-08
ATE417109T1 (de) 2008-12-15
EP1510580A3 (de) 2005-06-22
PT1510580E (pt) 2009-02-18
DE69534296D1 (de) 2005-08-18
JP2005290010A (ja) 2005-10-20
JP4298735B2 (ja) 2009-07-22
JP2002515005A (ja) 2002-05-21
IL185119A0 (en) 2007-12-03
DK1510580T3 (da) 2009-02-16
CA2195312A1 (en) 1996-02-15
EP0773957B1 (de) 2005-06-29
MY121563A (en) 2006-02-28
EP1510580A2 (de) 2005-03-02
DE69534296T2 (de) 2006-04-27
IL114775A (en) 2006-12-10
IL137840A0 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
WO1996004301A3 (en) Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
IL185119A0 (en) Method of producing a secreted hcv polypeptide
PT725824E (pt) Epitopos de celulas t humanas imunodominantes do virus da hepatite c
ATA257190A (de) Virales polypeptid
DE3786767D1 (de) Neues polypeptid.
DE59109221D1 (de) HCV-spezifische Peptide, Mittel dazu und ihre Verwendung
ATE125867T1 (de) Fibronektinbindungsprotein und dessen herstellung.
ATE206434T1 (de) Seroreaktive bereiche auf den hpv 16 proteinen e1 und e2
NO971875D0 (no) Cathepsin 02 protease
DK0732340T3 (da) Ekspression af porcine reproduktions- og respirationssyndromviruspolypeptider i den samme celle
DE3885969D1 (de) Neue 6-Acyl-(6H)-dibenz[c,e] [1,2]oxaphosphorin-6-oxyde, ihre Herstellung und Verwendung als Photoinitiatoren.
DE3579148D1 (de) Polypeptid und polypeptidzusammensetzung.
DE69715181D1 (de) Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
ATE438658T1 (de) Neue polypeptide aus bienengift und dessen gebrauchsverfahren
DK1012175T3 (da) Peptid med affinitet til koagulationsfaktor VIII
ATE82329T1 (de) Neue polypeptide, ihre herstellung und ihre verwendung.
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE59104129D1 (de) 2,2'-Thienyl-benzothiophene, ihre Herstellung und ihre Verwendung zur Bekämpfung von Schädlingen.
AU7387291A (en) Cellular binding protein having affinity for the regulatory region of the human papilloma virus type 18
DE69019581D1 (de) Polypeptid und dieses enthaltende antibaktierelle Präparate.
ATE55414T1 (de) Polypeptid und polypeptidzusammensetzung.
FI894215A0 (fi) Poliovirus polypeptid.
ATE92106T1 (de) Polypeptid und dessen herstellung.
DK494189D0 (da) Polypeptid

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0773957

Country of ref document: EP